Serengulam V Govindan

Principal investigator.

BiotechORCID
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
1994First federal award
$2.9MFederal grants as PI10 awards
2Patents grantedLatest Jul 22, 2025
201Papers5,282 citations
Career record

Federal awards and patents by year

19942025
AwardsPatents
Federal awards as principal investigator

10 awards · $2.9M

DateAgencyAwardAmountCompany
Jul 1, 2007NIHSBIR/STTR Phase II
MAb-based targeted chemotherapy of lung cancer
$240KImmunomedics
Jul 1, 2007NIHSBIR/STTR Phase II
MAb-based targeted chemotherapy of lung cancer
$725KImmunomedics
Jul 1, 2007NIHSBIR/STTR Phase I
MAb-based targeted chemotherapy of lung cancer
$114KImmunomedics
Sep 1, 2005NIHSBIR/STTR Phase II
An anti-CD74 MAb-drug conjugate for B-cell malignancies
$310KImmunomedics
Sep 1, 2005NIHSBIR/STTR Phase II
An anti-CD74 MAb-drug conjugate for B-cell malignancies
$492KImmunomedics
Jul 1, 2003NIHSBIR/STTR Phase I
Minimal-disease radioimmunotherapy of colorectal cancer
$100KImmunomedics
May 1, 1997NIHSBIR/STTR Phase II
IMPROVED RADIOIODINATION METHODS FOR RADIOIMMUNOTHERAPY
$275KImmunomedics
May 1, 1997NIHSBIR/STTR Phase II
IMPROVED RADIOIODINATION METHODS FOR RADIOIMMUNOTHERAPY
$475KImmunomedics
May 1, 1997NIHSBIR/STTR Phase I
IMPROVED RADIOIODINATION METHODS FOR RADIOIMMUNOTHERAPY
$100KImmunomedics
Jul 1, 1994NIHSBIR/STTR Phase I
PRACTICAL RE 186 LABELED PRODUCTS FOR RADIOIMMUNOTHERAPY
$81KImmunomedics
Patents

3 patents as inventor

Matched by the first inventor’s name and the patent’s company.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#646
Awards as PI#128
Patents#102
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.